• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Med Australas. SARS-CoV-2 Testing and Outcomes in the First 30 Days after the First Case of COVID-19 at an Australian Children's Hospital

tetano

Editor, Senior Moderator
Emerg Med Australas. 2020 May 10. doi: 10.1111/1742-6723.13550. [Epub ahead of print]
SARS-CoV-2 Testing and Outcomes in the First 30 Days after the First Case of COVID-19 at an Australian Children's Hospital.


Ibrahim LF[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3,[/SUP][SUP]4[/SUP], Tosif S[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], McNab S[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Hall S[SUP]1,[/SUP][SUP]2[/SUP], Lee HJ[SUP]5,[/SUP][SUP]6[/SUP], Lewena S[SUP]1,[/SUP][SUP]7,[/SUP][SUP]5[/SUP], Daley AJ[SUP]8[/SUP], Crawford N[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Steer A[SUP]1,[/SUP][SUP]2,[/SUP][SUP]9[/SUP], Bryant PA[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3,[/SUP][SUP]9,[/SUP][SUP]4[/SUP], Babl FE[SUP]1,[/SUP][SUP]7,[/SUP][SUP]5[/SUP].

Author information




Abstract

OBJECTIVE:

International studies describing COVID-19 in children have shown low proportions of paediatric cases and generally a mild clinical course. We aimed to present early data on children tested for SARS-CoV-2 at a large Australian tertiary children's hospital according to the state health department guidelines, which varied over time.
METHODS:

We conducted a retrospective cohort study at The Royal Children's Hospital, Melbourne, Australia. It included all paediatric patients (aged 0-18 years) who presented to the Emergency Department (ED) or the Respiratory Infection Clinic (RIC) and were tested for SARS-CoV-2. The 30-day study period commenced after the first confirmed positive case was detected at the hospital on 21[SUP]st[/SUP] March 2020, until 19[SUP]th[/SUP] April 2020. We recorded epidemiological and clinical data.
RESULTS:

There were 433 patients in whom SARS-CoV-2 testing was performed in ED (331 (76%)) or RIC (102 (24%)). There were 4 (0.9%) who had positive SARS-CoV-2 detected, none of whom were admitted to hospital or developed severe disease. Of these SARS-CoV-2 positive patients, 1/4 (25%) had a comorbidity, which was asthma. Of the SARS-CoV-2 negative patients, 196/429 (46%) had comorbidities. Risk factors for COVID-19 were identified in 4/4 SARS-CoV-2 positive patients and 47/429 (11%) SARS-CoV-2 negative patients.
CONCLUSIONS:

Our study identified a very low rate of SARS-CoV-2 positive cases in children presenting to a tertiary ED or RIC, none of whom were admitted to hospital. A high proportion of patients who were SARS-CoV-2 negative had comorbidities.
This article is protected by copyright. All rights reserved.



KEYWORDS:

Australia; COVID-19; SARS-CoV-2; children; novel coronavirus


PMID:32390285DOI:10.1111/1742-6723.13550
 
Back
Top Bottom